DENVER, CO--(NewMediaWire - Nov 1, 2016) - CEO of Ubiquitech
Software Corp. (OTC PINK: UBQU), with pending symbol and name change to
HempLife Today™, and the management of HempLife Today™ are
announcing that it has completed a very successful BETA test of the
previously announced (9.16.2016) Trial Offer of its popular
CannazALL™ CBD GelCaps and will now start this campaign to the
general public. This Trial Offer will differ slightly from the
originally announced offer and cost just $9.95 for shipping and
processing.
Through successful BETA testing the Company proved that it can
access more of the free traffic that is already coming to the
various Websites and Landing Pages the company operates. Company
data show that 20% - 40% of the existing traffic will take
advantage of this offer creating 25,000 - 50,000 new customers to
the CannazALL™ CBD brand by giving them the CBD experience that
converts them to becoming long term consumers.
This offer will consist of (6) 25mg CannazALL™ CBD GelCaps along
with a complete introduction to the company and instructions on how
to best benefit and have the best CBD experience possible. The
consumer will also receive an insert on other CannazALL™ products
as well as a 30% off coupon. The consumer will receive all of this
for a one-time cost of just $9.95 shipping and processing.
Because this Trial is offered to the existing traffic to the
Company's Websites and Landing Pages there are no additional
advertising costs to the Company. In addition, the shipping and
processing cost augments any expenses to the company and results in
a 100% net gain per new customer converted.
The Company data shows that charging a nominal amount ($9.95),
will create a better, more committed, customer to the CannazALL™
brand, but still result in the large percentage of new customers
taking advantage of this generous offer.
"With this offer we can get a sample of our product into the
hands of thousands of people monthly," said James Ballas,
CEO. "And once people experience our products our reorder
rate is incredible. This will add millions to our bottom line sales
without incurrent a penny in additional costs. We are very
fortunate to be in this position but that is the power of our
quality brand."
The Company bases its projections on the percentage of customers
who were converted by the Trial Offer during the BETA test period
and believes this will add 25,000 - 50,000 new customers over the
next 12-14 months, at zero advertising costs.
The company expects to have this offer on the "CBD Pricing" page
@ www.HempLifeToday.com as well as its
various Landing Pages, Social Media, and Content blogs by
Wednesday, November 9th.
About Ubiquitech (HempLife Today™)
Ubiquitech Software Corp, through its subsidiaries is a dynamic
multi-media, multi-faceted corporation utilizing state-of-the-art
global internet marketing, Direct Response (DRTV) Television,
Radio, and traditional marketing, to drive traffic to the new and
emerging multi-billion dollar industries like its subsidiary
HempLifeToday.com™
HempLifeToday™ focuses on the exciting and dynamic new thinking
in the world today that recognizes the important health and life
enriching enhancement that CBD Oil from the Hemp plant can bring.
Through its network of quality USA growers HempLifeToday.com™ has
developed multiple and proprietary CannazALL™ CBD oil products that
include; It's popular CBD Tinctures, Oils, GelCaps, CBD Powder,
Skin Salve, Wax Crumble, and e-liquid, all offered @ www.HempLifeToday.com
This press release contains forward-looking statements. Words
such as "expects", "intends'', "believes'', and similar expressions
reflecting something other than historical fact are intended to
identify forward-looking statements, but are not the exclusive
means of identifying such statements. These forward-looking
statements involve a number of risks and uncertainties, including
the timely development and market acceptance of products and
technologies, the ability to secure additional sources of finance,
the ability to reduce operating expenses, and other factors
described in the Company's filings with the OTC Markets Group. The
actual results that the Company achieves may differ materially from
any forward-looking statement due to such risks and uncertainties.
The Company undertakes no obligation to revise or update any
forward- looking statements in order to reflect events or
circumstances that may arise after the date of this release.